Sari Karkkainen
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.
Journal: Journal of Alzheimer's disease : JAD
Published: March 23, 2026
Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: January 23, 2026
Genetic architecture of Alzheimer's disease-related plasma biomarkers.
Journal: Neurobiology of aging
Published: January 20, 2026
Elevated Serum Neurofilament Light Chain Is Associated With Systemic Inflammation in Very Preterm Infants.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: December 16, 2025
Combining a computerized cognitive test with serum biomarkers improves detection of early-onset neurodegenerative disorders.
Journal: Journal of Alzheimer's disease : JAD
Published: October 27, 2025
Scalable biological-cognitive profiling for Alzheimer's disease in the population.
Journal: Brain communications
Published: August 04, 2025
Increased activity of Piezo1 channel in red blood cells is associated with Alzheimer's disease-related dementia.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 11, 2025
Cross-sectional study of plasma phosphorylated tau 217 in persons without dementia.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: October 11, 2024
TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer's disease.
Journal: BMJ open
Published: June 12, 2024
Frontotemporal dementia patient-derived iPSC neurons show cell pathological hallmarks and evidence for synaptic dysfunction and DNA damage.
Journal: Molecular psychiatry
Published: April 11, 2024
TWINGEN - protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer's disease.
Journal: medRxiv : the preprint server for health sciences
Published: November 15, 2023
Last Updated: 09/26/2026